awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38166329-922C2F69-41DB-4335-8CE3-59D727E1654E
Q38166329-922C2F69-41DB-4335-8CE3-59D727E1654E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38166329-922C2F69-41DB-4335-8CE3-59D727E1654E
Critical appraisal of ramucirumab (IMC-1121B) for cancer treatment: from benchside to clinical use.
P2860
Q38166329-922C2F69-41DB-4335-8CE3-59D727E1654E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38166329-922C2F69-41DB-4335-8CE3-59D727E1654E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6dc4f964cc03c2583fddd76a9082ece88d91c170
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.